Medtronic launches a new clinical trial examining renal denervation as a treatment for hypertension, aiming to settle the 'confounding factors' that led to the failure of its Symplicity-3 trial.
SynCardia says the FDA approved a clinical trial of its artificial heart as a bridge to transplant for patients with heart failure.
SynCardia Systems said today that it won FDA approval for a clinical trial of its artificial heart as a bridge to transplant for patients with heart failure.
InVivo Therapeutics adds the 4th site to a feasibility study of its biodegradable implant to treat acute spinal cord injuries.
Bioness says 4 patients were successfully implanted with its StimRouter neuromodulation device to treat their overactive bladders.
Bioness last week said it's making progress with a Canadian study of its StimRouter neuromodulation device designed to expand the number of conditions for which it can be used for treatment.
Armed with a recent $30 million funding found, Obalon Therapeutics launches a pivotal trial for its ingestible weight loss balloon.
California's Obalon Therapeutics said it launched a pivotal trial set for as many as 15 sites across the U.S. that will test its ingestible, gas-filled weight-loss balloon.
Manny Villafana, who founded St. Jude Medical and Kips Bay Medical, joins a last-gasp, $3 million funding round for Kips Bay.
InVivo Therapeutics adds a 3rd clinical site to a feasibility study of its biodegradable implant to treat acute spinal cord injuries.
Need Medtech news in a minute? We Deliver!
MassDevice +3,+5 and +7 newsletters get you caught up on all the mission critical news you need in med tech. Sign up today for our free newsletter.
News and information for the medical device industry and the companies that drive it. Learn the latest about sales, jobs, legislation and other areas of the medtech industry.